A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
Linda Stein Gold, MD
April W. Armstrong, MD, MPH
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
Joyce F. Liu, MD, MPH
MOA: CDH6-Targeted Antibody-Drug Conjugates
Kathleen Moore, MD, MS
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
Christyn Edmundson, MD
Neelam Goyal, MD
Evidence Base for Treatment Strategies for Endometrial Cancer After Disease Progression and Interdisciplinary Collaboration
Brian Slomovitz, MD
Casey Cosgrove, MD
Michelle Flint, WHNP-BS
Role of Predictive Biomarkers in Endometrial Cancer
Evidence- and Guideline-Based Treatment for Advanced/Metastatic Cervical Cancer
Evidence- and Guideline-Based Treatment for High-Risk Locally Advanced Cervical Cancer
Interdisciplinary Management of Gynecologic Cancers
Screening for Cervical Cancer
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.